Skip to main content

Characterization of Adeno-Associated Viral (AAV) Vector Proteins Using Maurice CE-SDS - application note

Application Notes

Application Notes Summary

Recent advances in vector engineering, delivery and safety have placed viral vector-based therapy at the forefront of gene therapy, with adeno-associated virus (AAV) being one of the most actively investigated. To support the rise of AAV vectors in the clinic, technological solutions that afford robust quality control assays are essential for implementing Good Manufacturing Practice (GMP), meeting regulatory requirements and ensuring the clinical quality, safety and consistency.

Request Literature

To access this literature content please fill out the form below.